Mutations in these genes are rare and early reports suggested that, on average, they are associated with moderate risks of breast cancer (lower than the high breast cancer risks associated with BRCA1 and BRCA2 mutations) [5,6,8,9]. This evidence concerns the gene BRCA2 and breast carcinoma.